Afula hospital to study effects of bariatric surgery on less-than-obese diabetics

Currently, the surgery is provided by the health funds only for diabetics who are morbidly obese.

January 20, 2015 00:06
1 minute read.
Overweight man

Overweight man [Illustrative]. (photo credit: INGIMAGE)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Although bariatric (stomach- shortening or tightening) surgery for some time has been known to improve and even cure type-2 diabetes and hypertension in the severely obese, surgeons are now considering the possibility it could do the same for those who are less or not at all overweight.

Dr. Nasser Sakran, a senior bariatric surgeon at Emek Medical Center in Afula and secretary of the Israeli Forum of Bariatric Surgery has launched the first Israeli study of its kind to determine whether this is true.

The national study, together with Hadassah University Medical Center diabetologist Prof. Itamar Raz, will examine whether diabetics with a body-mass index of less than 35 can significantly benefit from the operation.

It is believed that shortening or narrowing the stomach “fools” the metabolism into thinking the person is not diabetic.

Currently, the surgery is provided by the health funds only for diabetics who are morbidly obese.

Sakran said patients will be divided into three groups: one will continue to take only their diabetes medication as usual; the second will undergo an operation to insert a sleeve to reduce the stomach volume; and the third will have stomach- bypass surgery.

“We intend to follow up patients in the three groups for about a year and then process the data,” Sakran said. “We will decide whether medications are the answer or whether these patients should have bariatric surgery to improve or even cure their condition. Then, even improvement of 10 percent in their diabetes indices will turn bariatric surgery into an effective treatment.”

Sakran and Dr. Avraham Yishai of Emek’s diabetes clinic are seeking patients to take part in the study; suitable candidates are those who have had type-2 diabetes for several years, are taking medications, and are level-1 obesity with a BMI below 35.

Related Content

Defense Minister Avigdor Liberman
June 16, 2019
Social media figure Captain George claims Lapid, Liberman work together


Cookie Settings